在开创性生物疗法之后,不断发展生物分析策略
Federico Riccardi Sirtori1, Andrea Di Ianni1,2, Claudio Crosasso1
1NBE-DMPK Innovative BioAnalytics, RBM S.p.A., an affiliate of Merck KGaA, Darmstadt, Germany.
Bioanalysis
|August 19, 2025
概括
开发复杂的生物疗法,如多域生物疗法 (MDBs) 和抗体药物合物 (ADCs),需要先进的生物分析方法. 在药物开发过程中,联结试验 (LBA) 和LC-MS对于评估药理动力学,药理动力学和免疫性至关重要.
科学领域:
- 生物制药开发 生物制药开发
- 分析化学 分析化学
- 免疫学 免疫学 免疫学
背景情况:
- 多域生物疗法 (MDB) 和抗体药物合物 (ADC) 存在独特的发展挑战,包括复杂性和免疫性风险.
- 有效的生物分析方法对于评估新生物药物的药理动力学 (PK),药理动力学 (PD) 和免疫反应至关重要.
- 使用上下文 (CoU) 和监管合规对于在非临床和临床环境中定义和验证生物分析试验至关重要.
研究的目的:
- 审查最近关于生物分析技术的出版物,以支持MDB和ADC的发展.
- 讨论在生物治疗开发中使用连接物结合试验 (LBA) 和液态染色学-质谱学 (LC-MS) 的应用.
- 探索生物分析方法和复杂生物制品免疫性评估的最佳策略.
主要方法:
- 审查最近的科学文献,重点关注MDBs和ADCs的生物分析技术.
- 应用先进的技术,包括多重联体结合试验 (LBA).
- 利用液体染色学-质谱学 (LC-MS) 分析复杂的生物治疗药物及其生物转化.
主要成果:
- 带结合试验 (LBAs) 和LC-MS是表征复杂生物疗法的关键技术.
- 高分辨率质谱仪使生物生物转化能够在体内进行研究.
- 测试灵敏度,特异性和结构完整性的评估是关键的实际考虑.
结论:
- 使用LBA和LC-MS的强大的生物分析策略对于MDB和ADC的成功开发至关重要.
- 仔细考虑测试验证,CoU和监管要求,确保药物批准的可靠数据.
- 生物分析技术的持续进步对于应对新型生物疗法所带来的挑战至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314


